{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:09:59Z","timestamp":1780614599634,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012351","name":"Mitsubishi Tanabe Pharma Corp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012351","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.vaccine.2021.07.039","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T07:40:11Z","timestamp":1627285211000},"page":"4979-4987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Development and characterization of a plant-derived rotavirus-like particle vaccine"],"prefix":"10.1016","volume":"39","author":[{"given":"Natsuki","family":"Kurokawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Olivier","family":"Lavoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Andr\u00e9","family":"D'Aoust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon M.-J.","family":"Couture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Dargis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Tr\u00e9panier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohisa","family":"Tsutsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2021.07.039_b0005","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S1473-3099(18)30362-1","article-title":"Estimates of the global, regional and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"GBD 2016 Diarrhoeal Diseases Collaborators","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.07.039_b0010","first-page":"189","article-title":"Rotavirus proteins: structure and assembly","volume":"309","author":"Pesavento","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2021.07.039_b0015","series-title":"Field virology","first-page":"1917","article-title":"Rotaviruses","author":"Estes","year":"2007"},{"issue":"8","key":"10.1016\/j.vaccine.2021.07.039_b0020","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00705-008-0155-1","article-title":"Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments","volume":"153","author":"Matthijnssens","year":"2008","journal-title":"Arch Viol"},{"key":"10.1016\/j.vaccine.2021.07.039_b0025","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.meegid.2014.08.017","article-title":"Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure?","volume":"28","author":"D\u00f3r\u00f3","year":"2014","journal-title":"Infect Genet Evol"},{"issue":"5","key":"10.1016\/j.vaccine.2021.07.039_b0030","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/QCO.0000000000000572","article-title":"Current and new rotavirus vaccines","volume":"32","author":"Burke","year":"2019","journal-title":"Curr Opin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2021.07.039_b0035","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1473-3099(19)30126-4","article-title":"Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials","volume":"19","author":"Clark","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.039_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/mi.2014.114","article-title":"Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings","volume":"8","author":"Clarke","year":"2015","journal-title":"Mucosal Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.07.039_b0045","first-page":"145","article-title":"Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors","volume":"17","author":"Velasquez","year":"2018","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2021.07.039_b0050","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1311738","article-title":"Risk of intussusception after monovalent rotavirus vaccination","volume":"370","author":"Weintraub","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2021.07.039_b0055","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/CVI.00214-16","article-title":"Parenteral vaccination can be an effective means of inducing protective mucosal responses","volume":"23","author":"Clements","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2021.07.039_b0060","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Rold\u00e3o","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2021.07.039_b0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.smim.2017.08.014","article-title":"Major findings and recent advances in virus-like particle (VLP)-based vaccines","volume":"34","author":"Mohsen","year":"2017","journal-title":"Semin Immunol"},{"issue":"Pt B","key":"10.1016\/j.vaccine.2021.07.039_b0070","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nbt.2017.07.010","article-title":"Production of virus-like particles for vaccines","volume":"39","author":"Fuenmayor","year":"2017","journal-title":"N Biotechnol"},{"issue":"5","key":"10.1016\/j.vaccine.2021.07.039_b0075","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1128\/jvi.61.5.1488-1494.1987","article-title":"Synthesis and immunogenicity of the rotavirus major capsid antigen using a baculovirus expression system","volume":"61","author":"Estes","year":"1987","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2021.07.039_b0080","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.vaccine.2014.01.093","article-title":"Improved characteristics and protective efficacy in an animal model of E. coli-derived recombinant double-layered rotavirus virus-like particles","volume":"32","author":"Li","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.07.039_b0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1475-2859-10-33","article-title":"Molecular and process design for rotavirus-like particle production in Saccharomyces cerevisiae","volume":"10","author":"Rodr\u00edguez-Limas","year":"2011","journal-title":"Microb Cell Fact"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.039_b0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/vim.2006.19.42","article-title":"Production of rotavirus-like particles in tomamo (Lycopersicon esculentum L.) fruit by expression of capsid proteins VP2 and VP6 and immunological studies","volume":"19","author":"Salda\u00f1a","year":"2006","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2021.07.039_b0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12985-015-0436-8","article-title":"Engineering and expression of a human rotavirus candidate vaccine in Nicotiana benthamiana","volume":"12","author":"P\u00eara","year":"2015","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.vaccine.2021.07.039_b0100","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jviromet.2007.09.002","article-title":"Production of rotavirus-like particles in Spodoptera frugiperda larvae","volume":"147","author":"Molinari","year":"2008","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.039_b0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10529-010-0390-x","article-title":"Synthesis of double-layered rotavirus-like particles using internal ribosome entry site vector system in stably-transformed Drosophila melanogaster","volume":"33","author":"Lee","year":"2011","journal-title":"Biotechnol Lett"},{"issue":"9","key":"10.1016\/j.vaccine.2021.07.039_b0110","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/mt.2012.108","article-title":"HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice","volume":"20","author":"Laimbacher","year":"2012","journal-title":"Mol Ther"},{"issue":"11","key":"10.1016\/j.vaccine.2021.07.039_b0115","doi-asserted-by":"crossref","first-page":"738","DOI":"10.4161\/hv.5.11.9879","article-title":"Plant-based vaccines for potential human application: a review","volume":"5","author":"G\u00f3mez","year":"2009","journal-title":"Hum Vaccin"},{"issue":"2","key":"10.1016\/j.vaccine.2021.07.039_b0120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1586\/erv.12.147","article-title":"Virus-like particles produced in plants as potential vaccines","volume":"12","author":"Scotti","year":"2013","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2021.07.039_b0125","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1467-7652.2009.00496.x","article-title":"The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza","volume":"8","author":"D\u2019Aoust","year":"2010","journal-title":"Plant Biotechnol J"},{"issue":"49","key":"10.1016\/j.vaccine.2021.07.039_b0130","doi-asserted-by":"crossref","first-page":"8228","DOI":"10.1016\/j.vaccine.2007.09.061","article-title":"Production of recombinant HIV-1\/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine","volume":"25","author":"Greco","year":"2007","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2021.07.039_b0135","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.vaccine.2004.11.017","article-title":"Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses","volume":"23","author":"Huang","year":"2005","journal-title":"Vaccine"},{"issue":"46","key":"10.1016\/j.vaccine.2021.07.039_b0140","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1016\/j.vaccine.2015.09.065","article-title":"Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets","volume":"33","author":"Pillet","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.07.039_b0145","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clim.2016.03.008","article-title":"A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults","volume":"168","author":"Pillet","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2021.07.039_b0150","series-title":"Molecular cloning: a laboratory manual","author":"Sambrook","year":"2001"},{"key":"10.1016\/j.vaccine.2021.07.039_b0155","unstructured":"Lavoie PO, D\u2019Aoust MA. Rotavirus-like particle production in plants. WO2016\/115630; 2016."},{"key":"10.1016\/j.vaccine.2021.07.039_b0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1746-4811-4-4","article-title":"Protocol: streamline cloning of genes into binary vectors in Agrobacterium via the Gateway\u00ae TOPO vector system","volume":"4","author":"Xu","year":"2008","journal-title":"Plant Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.039_b0165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/vim.2005.18.27","article-title":"Rotavirus NSP4: a multifunctional viral enterotoxin","volume":"18","author":"Ball","year":"2005","journal-title":"Viral Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.039_b0170","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1128\/JVI.79.1.184-192.2005","article-title":"Silencing the morphogenesis of rotavirus","volume":"79","author":"L\u00f3pez","year":"2005","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.07.039_b0175","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/infdis\/jiq031","article-title":"Immune responses to rotavirus infection and vaccination and associated correlates of protection","volume":"203","author":"Desselberger","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.07.039_b0180","doi-asserted-by":"crossref","first-page":"43487","DOI":"10.1038\/srep43487","article-title":"The rotavirus NSP4 viroporin domain is a calcium-conducting ion channel","volume":"7","author":"Pham","year":"2017","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.vaccine.2021.07.039_b0185","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1128\/jvi.63.11.4553-4562.1989","article-title":"Receptor activity of rotavirus nonstructural glycoprotein NS28","volume":"63","author":"Au","year":"1989","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.039_b0190","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0042-6822(89)90515-1","article-title":"Interaction of rotavirus cores with the nonstructural glycoprotein NS28","volume":"171","author":"Meyer","year":"1989","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2021.07.039_b0195","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1954","article-title":"Rotavirus virus-like particles (RV-VLPs) vaccines: an update","volume":"27","author":"Changotra","year":"2017","journal-title":"Rev Med Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2021.07.039_b0200","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1128\/jvi.68.9.5945-5952.1994","article-title":"Characterization of virus-like particles by the expression of rotavirus capsid proteins in insect cells","volume":"68","author":"Crawford","year":"1994","journal-title":"J Virol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2021.07.039_b0205","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1093\/infdis\/174.Supplement_1.S88","article-title":"Virus-like particles as a rotavirus subunit vaccine","volume":"174","author":"Conner","year":"1996","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2021.07.039_b0210","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bej.2009.02.006","article-title":"Challenges for the production of virus-like particles in insect cells: the case of rotavirus-like particles","volume":"45","author":"Palomares","year":"2009","journal-title":"Biochem Eng J"},{"issue":"19","key":"10.1016\/j.vaccine.2021.07.039_b0215","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0264-410X(98)00319-3","article-title":"Biochemical and immunologic comparison of virus-like particles for a rotavirus subunit vaccine","volume":"17","author":"Madore","year":"1999","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2021.07.039_b0220","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1016\/S0264-410X(03)00308-6","article-title":"Immunogenicity and protective efficacy of rotavirus 2\/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice","volume":"21","author":"Bertolotti-Ciarlet","year":"2003","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2021.07.039_b0225","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0264-410X(98)00317-X","article-title":"Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles","volume":"17","author":"Jiang","year":"1999","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2021.07.039_b0230","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.1128\/JVI.72.11.9233-9246.1998","article-title":"Subunit rotavirus vaccine administered parenterally to rabbits induce active protective immunity","volume":"72","author":"Ciarlet","year":"1998","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2021.07.039_b0235","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1128\/jvi.64.8.3635-3642.1990","article-title":"Polypeptide composition of rotavirus empty capsids and their possible use as a subunit vaccine","volume":"64","author":"Br\u00fcssow","year":"1990","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.039_b0240","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0042-6822(92)90291-V","article-title":"Neutralizing epitopes on herpes simplex virus-1-expressed rotavirus VP7 are dependent on coexpression of other rotavirus proteins","volume":"187","author":"Dormitzer","year":"1992","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2021.07.039_b0245","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1128\/JVI.73.6.4813-4822.1999","article-title":"Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles","volume":"73","author":"Crawford","year":"1999","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.039_b0250","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.etp.2008.07.003","article-title":"Histopathological lesions following intramuscular administration of saline in laboratory rodents and rabbits","volume":"61","author":"Thuilliez","year":"2009","journal-title":"Exp Toxicol Pathol"},{"issue":"11","key":"10.1016\/j.vaccine.2021.07.039_b0255","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.vaccine.2004.09.012","article-title":"Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the Cynomolgus monkey","volume":"23","author":"Verdier","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.07.039_b0260","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/toxsci\/kfj170","article-title":"Toxicological safety evaluation of DNA plasmid vaccines against HIV-1, Ebora, Severe Acute Respiratory Syndrome, or West Nile virus is similar despite differing plasmid backbones or gene-inserts","volume":"91","author":"Sheets","year":"2006","journal-title":"Toxicol Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2021.07.039_b0265","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0272-0590(88)90288-6","article-title":"Local reactions of the saponin Quil A and a QuilA containing iscom measles vaccine after intramuscular injection of rats: a comparison with the effect of DPT-polio vaccine","volume":"10","author":"Speijers","year":"1988","journal-title":"Fundam Appl Toxicol"},{"key":"10.1016\/j.vaccine.2021.07.039_b0270","unstructured":"Kurokawa N, Robinson M, Bernard C, Kawaguchi Y, Koujin Y, Koen A, Madhi S, Polasek TM, McNeal M, Dargis M, Couture MM, Tr\u00e9panier S, Forrest BD, Tsutsui N. Safety and immunogenicity of a plant-derived rotavirus-like particle vaccine in adults, toddlers and infants. (Submitted)."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21009166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21009166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:59:08Z","timestamp":1759402748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21009166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":54,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0264410X21009166"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and characterization of a plant-derived rotavirus-like particle vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}